(From left) Hyunji Yoon, Integrated Master's and PhD student in Biological Sciences at GIST, Professor Jungseok Nam, Dr. Choongjae Lee. Provided by GIST

(From left) Hyunji Yoon, Integrated Master's and PhD student in Biological Sciences at GIST, Professor Jungseok Nam, Dr. Choongjae Lee. Provided by GIST

View original image

Gwangju Institute of Science and Technology (GIST) announced on January 28 that the research team led by Professor Jungseok Nam from the Department of Biological Sciences has identified how the "acidic tumor microenvironment," which promotes metastasis and malignancy in colorectal cancer, is formed, and has pinpointed "Dysadherin" as the key protein driving this process.


This study elucidates, at the molecular level, the principle by which cancer creates an environment favorable for its own growth, thereby suggesting the potential for new therapeutic strategies.


Colorectal cancer is known to have both high incidence and mortality rates worldwide. Many patients are diagnosed at an advanced stage, making treatment challenging and prognosis poor.

Elucidation of Cancer Metastasis Mechanism Mediated by Dishevelled-CA9 Axis.

Elucidation of Cancer Metastasis Mechanism Mediated by Dishevelled-CA9 Axis.

View original image

Recently, research has been actively conducted to identify the causes of cancer not only in genetic abnormalities but also in the tumor microenvironment?the environment surrounding cancer cells. The tumor microenvironment includes not only cellular components such as immune cells and fibroblasts around cancer cells, but also physical and chemical conditions such as hypoxia, nutrient deficiency, and acidification.


In particular, it is known that when the area surrounding the tumor becomes acidic, the immune cells' ability to attack is weakened, and cancer cells are more likely to invade surrounding tissues or spread to other organs. However, how this acidic environment is created and maintained has not been clearly understood.


Starting from this question, the research team focused on Dysadherin, a cell membrane protein involved in cancer progression and metastasis. Dysadherin is rarely expressed in normal tissues but is highly expressed in various cancers. In previous studies, the team had already revealed that this protein plays a significant role in the development and progression of colorectal cancer.


In this study, through single-cell data analysis of colorectal cancer patients and mouse tumor model experiments, the team confirmed that tumors with high Dysadherin expression had a more acidic surrounding environment, and that the aggressiveness and risk of recurrence of the cancer increased significantly.


Even within the same acidic environment, cancer cells with high levels of Dysadherin grew faster, migrated better, and showed a much higher ability to invade other tissues. This indicates that Dysadherin acts as a "switch" that promotes the malignancy of cancer cells in an acidic environment.


The team was able to identify, for the first time, the specific process by which Dysadherin alters the properties of cancer cells. The analysis showed that Dysadherin activates intracellular signaling pathways in cancer cells, increasing the production of a protein called Carbonic Anhydrase-9 (CA9).


The researchers found that CA9 expels acidic substances accumulated inside cancer cells to the outside, maintaining relative stability within the cancer cells while making the tumor microenvironment even more acidic. In other words, cancer cells use Dysadherin and CA9 to create an environment favorable for their own survival, while simultaneously transforming the surrounding area into a state that further supports cancer growth. This acidic environment alters the energy metabolism of cancer cells, reduces the anti-cancer function of immune cells (T cells), and activates fibroblasts that support tumor growth, thereby restructuring the entire tumor microenvironment to favor cancer cells.


Furthermore, the team developed a peptide that inhibits the function of Dysadherin and applied it to colorectal cancer cells. As a result, the ability of cancer cells to create an acidic environment was noticeably reduced, and consequently, the growth and proliferation of cancer cells were significantly suppressed.


This experimentally demonstrates that Dysadherin regulates tumor acidification via the FAK?STAT3?CA9 signaling pathway, showing that therapeutic strategies targeting Dysadherin can indeed suppress cancer malignancy.


This study is significant in that it reveals Dysadherin is not merely a marker of cancer progression, but plays a central role in simultaneously altering both the properties of cancer cells and the tumor microenvironment, thereby exacerbating the malignancy of colorectal cancer.


Professor Jungseok Nam stated, "This study elucidated, at the molecular level, including the specific signal transduction process, how cancer cells manipulate their surrounding environment to their own advantage. We expect this could lead to the development of new therapeutic strategies to control tumor malignancy and metastasis in the future."



This research was led by Professor Jungseok Nam, with Dr. Choongjae Lee and doctoral candidate Hyunji Yoon as co?first authors. It was supported by the Mid-Career Researcher Program, Bio-Medical Technology Development Program, Global Research Center Program (IRC) of the Ministry of Science and ICT and the National Research Foundation of Korea, as well as the GIST Research Institute (GRI). The results were published on January 15 in the internationally renowned journal "Signal Transduction and Targeted Therapy," part of the Nature portfolio, specializing in biomedical sciences and molecular signaling.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing